Changing trends of primary malignant neoplasms (PMN) in children (C) 0-15 yr and young adults (YA) 16-35 yr (Meeting abstract). NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Changing trends of primary malignant neoplasms (PMN) in children (C) 0-15 yr and young adults (YA) 16-35 yr (Meeting abstract).

Proc Annu Meet Am Soc Clin Oncol; 13:A535 1994. Unique Identifier : AIDSLINE ICDB/94600531
Samuel J; Goyal V; Cook County Hosp., Chicago, IL 60612

Abstract: From January 1984 to December 1991, 7949 patients (pts) with cancer were reported in the tumor registry. 822 pts (10%) were up to age 35, of which 90 (10%) were in C, females (54%). The common PMN were cervix 23%, lymphoma and leukemia (L) 18%, Kaposi's Sarcoma (KS) (10%), breast 6% and brain 6%. In C, it was L 36% followed by brain 23%. In YA, it was cervix, KS, L, breast. 84% of cervix was Stage 0 and 1 remained constant over the years. Data are presented in a table. Findings: Though AIDS is on the rise, lymphoma is not increasing. Cervical CA is declining and to the contrary KS shows an upward trend. Breast CA also is decreasing in recent years which is reported in the screened population. Brain tumor in C is increasing.
Keywords: Adolescence Adult Brain Neoplasms/EPIDEMIOLOGY Breast Neoplasms/EPIDEMIOLOGY Cervix Neoplasms/EPIDEMIOLOGY Child Child, Preschool Epidemiology/TRENDS Female Human Infant Leukemia/EPIDEMIOLOGY Lymphoma/EPIDEMIOLOGY Male Neoplasms/*EPIDEMIOLOGY Sarcoma, Kaposi's/EPIDEMIOLOGY ABSTRACT

KWDadolescenceadultbrainneoplasms/epidemiologybreastneoplasms/epidemiologycervixneoplasms/epidemiologychildchild,preschoolepidemiology/trendsfemalehumaninfantleukemia/epidemiologylymphoma/epidemiologymaleneoplasms/KWDepidemiologysarcoma,kaposi's/epidemiologyabstract
940930
M9491052

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .